• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

E-132 Successful mechanical thrombectomy in an 11-year-old patient with emergent large vessel occlusion acute ischemic stroke related to congenital complete heart block and recent covid-19 infection
ConclusionsThis is a first known report of a successful mechanical thrombectomy in a pediatric patient due to a large vessel occlusion related to congenital complete heart block and recent COVID-19 infection.Disclosures J. Ansari: None. D. Mata Canadas: None. M. Ayub: None. J. Caskey: None. P. Simoncini: None. R. Riel-Romero: None. P. Sharma: None. D. Jordan: None. H. Cuellar: None.
Source: Journal of NeuroInterventional Surgery - July 30, 2023 Category: Neurosurgery Authors: Ansari, J., Mata Canadas, D., Ayub, M., Caskey, J., Simoncini, P., Riel-Romero, R., Sharma, P., Jordan, D., Cuellar, H. Tags: SNIS 20th annual meeting electronic poster abstracts Source Type: research

Stroke-related risk factors during pregnancy in women who underwent metabolic and bariatric surgery compared with women who have not undergone metabolic and bariatric surgery
CONCLUSIONS: MBS helps women lose weight and decrease the incidence of some pregnancy-related risk factors for stroke. However, there is a notable racial health disparity.PMID:37150625 | DOI:10.1016/j.soard.2023.03.017
Source: Surgery for Obesity and Related Diseases : official journal of the American Society for Bariatric Surgery - May 7, 2023 Category: Surgery Authors: Kara M Christopher Xiaoyi Gao Ahmed Abdelsalam Brian Miremadi Jordan Scott Chike Ilorah Pamela Xaverius Guillermo Linares Source Type: research

Warfarin adherence and anticoagulation control in atrial fibrillation patients: a systematic review
CONCLUSIONS: While the available evidence is limited, this systematic review demonstrated a positive finding of the association between warfarin adherence and anticoagulation control in patients with AF.PMID:34982455 | DOI:10.26355/eurrev_202112_27642
Source: European Review for Medical and Pharmacological Sciences - January 4, 2022 Category: Drugs & Pharmacology Authors: M Ababneh S A Nasser A Rababa'h F Ababneh Source Type: research

Endovascular versus open surgical repair for complicated chronic Type B aortic dissection
CONCLUSIONS: Due to lack of RCTs or CCTs investigating the effectiveness and safety of TEVAR compared to OSR for patients with complicated CBAD, we are unable to provide any evidence to inform decision-making on the optimal intervention for these patients. High-quality RCTs or CCTs addressing this objective are necessary. However, conducting such studies will be challenging for this life-threatening disease.PMID:34905228 | DOI:10.1002/14651858.CD012992.pub2
Source: Cochrane Database of Systematic Reviews - December 14, 2021 Category: General Medicine Authors: Fionnuala Jordan Brian FitzGibbon Edel P Kavanagh Peter McHugh Dave Veerasingam Sherif Sultan Niamh Hynes Source Type: research

Apixaban and rivaroxaban use for atrial fibrillation in patients with obesity and BMI ≥50 kg/m2
ConclusionsThis study demonstrated that apixaban and rivaroxaban in patients with a BMI ≥50 kg/m2 for treatment of NVAF may be safe and effective at preventing thromboembolic events and had no increased risk of bleeding. Although, findings should be interpreted with caution and confirmed with additional studies. This study contributes to the growing body of evidence that direct oral anticoagulants (DOACs) may be effective and safe to use for the treatment of NVAF in patients with BMI ≥50 kg/m2.
Source: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - December 13, 2021 Category: Drugs & Pharmacology Authors: Cavan P. O ’Kane, Juan Carlo O. Avalon, Jordan L. Lacoste, Wei Fang, Christopher M. Bianco, Laura Davisson, Kara L. Piechowski Tags: ORIGINAL RESEARCH ARTICLE Source Type: research

Apixaban and rivaroxaban use for atrial fibrillation in patients with obesity and BMI ≥50 kg/m2
ConclusionsThis study demonstrated that apixaban and rivaroxaban in patients with a BMI ≥50 kg/m2 for treatment of NVAF may be safe and effective at preventing thromboembolic events and had no increased risk of bleeding. Although, findings should be interpreted with caution and confirmed with additional studies. This study contributes to the growing body of evidence that direct oral anticoagulants (DOACs) may be effective and safe to use for the treatment of NVAF in patients with BMI ≥50 kg/m2.
Source: Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy - November 25, 2021 Category: Drugs & Pharmacology Authors: Cavan P. O ’Kane, Juan Carlo O. Avalon, Jordan L. Lacoste, Wei Fang, Christopher M. Bianco, Laura Davisson, Kara L. Piechowski Tags: ORIGINAL RESEARCH ARTICLE Source Type: research

B-po04-143 safety and feasibility of reactive atrial-based anti-tachycardia pacing algorithm in cardiovascular implantable electronic devices to suppress atrial fibrillation in patients with left atrial appendage closure device
Reactive atrial-based anti-tachycardia pacing (rATP) in CIED (cardiovascular implantable electronic devices) are effective in AF suppression. Uninterrupted systemic anticoagulation is mandated when these algorithms are activated to avoid stroke and systemic thromboembolism. However, the use of rATP algorithm in patients with left atrial appendage (LAA) closure device without ongoing anticoagulation has not been studied.
Source: Heart Rhythm - July 28, 2021 Category: Cardiology Authors: Rayan El-Zein, Jordan Luli, Ishmail Saccoh, Cody Carter, Mitchell Stelzer, Emily M. Gates, Zeryab Khan, Ankur N. Shah, James M. Kleman, Sreedhar R. Billakanty, Anish K. Amin, Nagesh Chopra Source Type: research

Pages: 1  2